Pengfei Zhou

Biolake City C2-1, No. 666 Gaoxin Road
Wuhan, 430075, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 36 publications

Targeted FcRn to deliver epitope-optimized RBD confers broad-spectrum mucosal protection against SARS-CoV-2.

Targeted FcRn to deliver epitope-optimized RBD confers broad-spectrum mucosal protection against SARS-CoV-2.

Journal: Molecular therapy. Nucleic acids

Published: March 27, 2026

Hepatocytes functionally reprogrammed by KIAA1199-high colorectal cancer cells favour the accumulation of pro-metastatic Egr1+ neutrophils.

Hepatocytes functionally reprogrammed by KIAA1199-high colorectal cancer cells favour the accumulation of pro-metastatic Egr1+ neutrophils.

Journal: Nature communications

Published: September 09, 2025

Universal broad-spectrum mucosal vaccine design for human coronaviruses inspired by artificial antibodies.

Universal broad-spectrum mucosal vaccine design for human coronaviruses inspired by artificial antibodies.

Journal: NPJ vaccines

Published: August 31, 2025

Development and clinical trial of M701, an Anti-EpCAM × Anti-CD3 bispecific antibody: a targeted intraperitoneal therapy for malignant ascites stemming from advanced solid tumors.

Development and clinical trial of M701, an Anti-EpCAM × Anti-CD3 bispecific antibody: a targeted intraperitoneal therapy for malignant ascites stemming from advanced solid tumors.

Journal: Experimental hematology & oncology

Published: July 24, 2025

Spatial Regulation of Cancer-Associated Fibroblasts and Tumor Cells via pH-Responsive Bispecific Antibody Delivery for Enhanced Chemo-Immunotherapy Synergy.

Spatial Regulation of Cancer-Associated Fibroblasts and Tumor Cells via pH-Responsive Bispecific Antibody Delivery for Enhanced Chemo-Immunotherapy Synergy.

Journal: ACS nano

Published: March 21, 2025

Bispecific Antibody Targeting VEGF/TGF-β Synergizes with Local Radiotherapy: Turning Tumors from Cold to Inflamed and Amplifying Abscopal Effects.

Bispecific Antibody Targeting VEGF/TGF-β Synergizes with Local Radiotherapy: Turning Tumors from Cold to Inflamed and Amplifying Abscopal Effects.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: January 28, 2025

Targeting pyroptosis reverses KIAA1199-mediated immunotherapy resistance in colorectal cancer.

Targeting pyroptosis reverses KIAA1199-mediated immunotherapy resistance in colorectal cancer.

Journal: Journal for immunotherapy of cancer

Published: January 23, 2025

Anti-TGF-β/PD-L1 bispecific antibody synergizes with radiotherapy to enhance antitumor immunity and mitigate radiation-induced pulmonary fibrosis.

Anti-TGF-β/PD-L1 bispecific antibody synergizes with radiotherapy to enhance antitumor immunity and mitigate radiation-induced pulmonary fibrosis.

Journal: Journal of hematology & oncology

Published: August 28, 2024

Blockade of CCR5+ T Cell Accumulation in the Tumor Microenvironment Optimizes Anti-TGF-β/PD-L1 Bispecific Antibody.

Blockade of CCR5+ T Cell Accumulation in the Tumor Microenvironment Optimizes Anti-TGF-β/PD-L1 Bispecific Antibody.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: July 25, 2024

Single dual-specific anti-PD-L1/TGF-β antibody synergizes with chemotherapy as neoadjuvant treatment for pancreatic ductal adenocarcinoma: a preclinical experimental study.

Single dual-specific anti-PD-L1/TGF-β antibody synergizes with chemotherapy as neoadjuvant treatment for pancreatic ductal adenocarcinoma: a preclinical experimental study.

Journal: International journal of surgery (London, England)

Published: November 23, 2023

Protection of the receptor binding domain (RBD) dimer against SARS-CoV-2 and its variants.

Protection of the receptor binding domain (RBD) dimer against SARS-CoV-2 and its variants.

Journal: Journal of virology

Published: October 16, 2023

Synergistic efficacy of simultaneous anti-TGF-β/VEGF bispecific antibody and PD-1 blockade in cancer therapy.

Synergistic efficacy of simultaneous anti-TGF-β/VEGF bispecific antibody and PD-1 blockade in cancer therapy.

Journal: Journal of hematology & oncology

Published: April 14, 2023

Showing 1-12 of 36

Last Updated: 09/26/2026